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Introduction
In previous studies, we have established an immune-mediated model of endogenous neuroprotection following facial nerve axotomy in wild-type (WT) and immunodeficient recombinase activating gene-2 knock-out (RAG2 À/À ) mice lacking functionally mature B and T cells, but intrinsically maintaining antigen presentation by MHC class II-expressing peripheral antigen-presenting cells (APC; Serpe et al., 1999 Serpe et al., , 2003 . Key to immune-mediated neuroprotection after axotomy is the generation of neuroprotective CD4 + T cells that are antigen-specific and require: (1) initial activation peripherally, via interaction with MHC class II-expressing APC, and (2) re-activation centrally, via interaction with MHC class IIexpressing microglia (Byram et al., 2004) . Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in motoneuron degeneration and accompanied by neuroinflammation involving reactive microglia and astrocytes centrally and immune activation peripherally (Appel et al., 2010;  http://dx.doi.org/10.1016/j.bbi.2014.05.019 0889-1591/Ó 2014 Elsevier Inc. All rights reserved.
